• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同质且功能性人诱导多能干细胞来源的肝类器官的高通量生物工程微图案化技术。

High-throughput bioengineering of homogenous and functional human-induced pluripotent stem cells-derived liver organoids micropatterning technique.

作者信息

Xu Xiaodong, Jiang Shanqing, Gu Longjun, Li Bin, Xu Fang, Li Changyong, Chen Pu

机构信息

Tissue Engineering and Organ Manufacturing (TEOM) Lab, Department of Biomedical Engineering, Wuhan University TaiKang Medical School (School of Basic Medical Sciences), Wuhan, China.

Hubei Province Key Laboratory of Allergy and Immunology, Wuhan University TaiKang Medical School (School of Basic Medical Sciences), Wuhan, China.

出版信息

Front Bioeng Biotechnol. 2022 Aug 10;10:937595. doi: 10.3389/fbioe.2022.937595. eCollection 2022.

DOI:10.3389/fbioe.2022.937595
PMID:36032707
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9399390/
Abstract

Human pluripotent stem cell-derived liver organoids are emerging as more human-relevant models for studying liver diseases and hepatotoxicity than traditional hepatocyte cultures and animal models. The generation of liver organoids is based on the Matrigel dome method. However, the organoids constructed by this method display significant heterogeneity in their morphology, size, and maturity. Additionally, the formed organoid is randomly encapsulated in the Matrigel dome, which is not convenient for staining and imaging. Here, we demonstrate an approach to generate a novel type of liver organoids via micropatterning technique. This approach enables the reproducible and high-throughput formation of bioengineered fetal liver organoids with uniform morphology and deterministic size and location in a multiwell plate. The liver organoids constructed by this technique closely recapitulate some critical features of human liver development at the fetal stage, including fetal liver-specific gene and protein expression, glycogen storage, lipid accumulation, and protein secretion. Additionally, the organoids allow whole-mount staining and imaging. Overall, this new type of liver organoids is compatible with the pharmaceutical industry's widely-used preclinical drug discovery tools and will facilitate liver drug screening and hepatotoxic assessment.

摘要

与传统的肝细胞培养和动物模型相比,人多能干细胞衍生的肝脏类器官正成为研究肝脏疾病和肝毒性的更具人体相关性的模型。肝脏类器官的生成基于基质胶穹顶法。然而,用这种方法构建的类器官在形态、大小和成熟度方面表现出显著的异质性。此外,形成的类器官随机包裹在基质胶穹顶中,这不利于染色和成像。在此,我们展示了一种通过微图案化技术生成新型肝脏类器官的方法。这种方法能够在多孔板中以可重复且高通量的方式形成具有均匀形态、确定大小和位置的生物工程化胎儿肝脏类器官。通过该技术构建的肝脏类器官紧密再现了胎儿期人类肝脏发育的一些关键特征,包括胎儿肝脏特异性基因和蛋白质表达、糖原储存、脂质积累和蛋白质分泌。此外,这些类器官允许进行整体染色和成像。总体而言,这种新型肝脏类器官与制药行业广泛使用的临床前药物发现工具兼容,并将促进肝脏药物筛选和肝毒性评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ac/9399390/707cd9b87cf9/fbioe-10-937595-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ac/9399390/232125b8b2cf/fbioe-10-937595-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ac/9399390/dc4d3270a410/fbioe-10-937595-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ac/9399390/e33667a27707/fbioe-10-937595-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ac/9399390/d2a2345b36fc/fbioe-10-937595-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ac/9399390/707cd9b87cf9/fbioe-10-937595-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ac/9399390/232125b8b2cf/fbioe-10-937595-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ac/9399390/dc4d3270a410/fbioe-10-937595-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ac/9399390/e33667a27707/fbioe-10-937595-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ac/9399390/d2a2345b36fc/fbioe-10-937595-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/95ac/9399390/707cd9b87cf9/fbioe-10-937595-g005.jpg

相似文献

1
High-throughput bioengineering of homogenous and functional human-induced pluripotent stem cells-derived liver organoids micropatterning technique.同质且功能性人诱导多能干细胞来源的肝类器官的高通量生物工程微图案化技术。
Front Bioeng Biotechnol. 2022 Aug 10;10:937595. doi: 10.3389/fbioe.2022.937595. eCollection 2022.
2
Development of a high-throughput micropatterned agarose scaffold for consistent and reproducible hPSC-derived liver organoids.高通量微图案琼脂糖支架的开发用于一致且可重复的 hPSC 来源的肝类器官。
Biofabrication. 2022 Oct 28;15(1). doi: 10.1088/1758-5090/ac933c.
3
Generation of human liver organoids from pluripotent stem cell-derived hepatic endoderms.从多能干细胞衍生的肝内胚层生成人肝脏类器官。
PeerJ. 2020 Oct 19;8:e9968. doi: 10.7717/peerj.9968. eCollection 2020.
4
Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.扩增型人多能干细胞来源的肝样类器官的生成。
J Hepatol. 2019 Nov;71(5):970-985. doi: 10.1016/j.jhep.2019.06.030. Epub 2019 Jul 9.
5
Regenerative human liver organoids (HLOs) in a pillar/perfusion plate for hepatotoxicity assays.用于肝毒性检测的柱形/灌注板中的再生人肝类器官(HLOs)。
bioRxiv. 2024 Nov 3:2024.03.25.586638. doi: 10.1101/2024.03.25.586638.
6
Efficient and reproducible generation of human induced pluripotent stem cell-derived expandable liver organoids for disease modeling.高效且可重现的人类诱导多能干细胞衍生可扩增肝类器官的生成,用于疾病建模。
Sci Rep. 2023 Dec 22;13(1):22935. doi: 10.1038/s41598-023-50250-w.
7
Prediction of Acute Hepatotoxicity With Human Pluripotent Stem Cell-Derived Hepatic Organoids.基于人多能干细胞衍生的类肝器官预测急性肝毒性。
Curr Protoc. 2024 Apr;4(4):e1015. doi: 10.1002/cpz1.1015.
8
Challenges for the Applications of Human Pluripotent Stem Cell-Derived Liver Organoids.人多能干细胞衍生肝类器官应用面临的挑战。
Front Cell Dev Biol. 2021 Oct 1;9:748576. doi: 10.3389/fcell.2021.748576. eCollection 2021.
9
A fully automated high-throughput workflow for 3D-based chemical screening in human midbrain organoids.一种全自动高通量工作流程,用于基于 3D 的人类中脑细胞类器官中的化学筛选。
Elife. 2020 Nov 3;9:e52904. doi: 10.7554/eLife.52904.
10
Uniform cerebral organoid culture on a pillar plate by simple and reproducible spheroid transfer from an ultralow attachment well plate.通过简单且可重复的从超低附着培养板转移到柱状培养板来实现脑类器官的均匀培养。
Biofabrication. 2024 Jan 16;16(2). doi: 10.1088/1758-5090/ad1b1e.

引用本文的文献

1
Organoids in Haematologic Research: Advances and Future Directions.血液学研究中的类器官:进展与未来方向
Cell Prolif. 2025 Jun;58(6):e13806. doi: 10.1111/cpr.13806. Epub 2025 Jan 26.
2
High-Throughput Formation of Pre-Vascularized hiPSC-Derived Hepatobiliary Organoids on a Chip via Nonparenchymal Cell Grafting.通过非实质细胞移植在芯片上高通量形成预血管化的人诱导多能干细胞衍生的肝胆类器官
Adv Sci (Weinh). 2025 Feb;12(8):e2407945. doi: 10.1002/advs.202407945. Epub 2025 Jan 4.
3
Reproducible generation of human liver organoids (HLOs) on a pillar plate platform microarray 3D bioprinting.

本文引用的文献

1
Application of 3D Hepatic Plate-Like Liver Model for Statin-Induced Hepatotoxicity Evaluation.3D肝板样肝脏模型在他汀类药物诱导的肝毒性评估中的应用
Front Bioeng Biotechnol. 2022 Mar 17;10:826093. doi: 10.3389/fbioe.2022.826093. eCollection 2022.
2
Liver injury associated with drug intake during pregnancy.孕期药物摄入相关的肝损伤。
World J Hepatol. 2021 Jul 27;13(7):747-762. doi: 10.4254/wjh.v13.i7.747.
3
Gene Regulatory Network Analysis and Engineering Directs Development and Vascularization of Multilineage Human Liver Organoids.
在柱状板平台微阵列 3D 生物打印技术上可重现地生成人类肝类器官(HLO)。
Lab Chip. 2024 May 14;24(10):2747-2761. doi: 10.1039/d4lc00149d.
4
Toward reproducible tumor organoid culture: focusing on primary liver cancer.迈向可重现的肿瘤类器官培养:聚焦原发性肝癌。
Front Immunol. 2024 Mar 20;15:1290504. doi: 10.3389/fimmu.2024.1290504. eCollection 2024.
5
Application Prospect of Induced Pluripotent Stem Cells in Organoids and Cell Therapy.诱导多能干细胞在类器官和细胞治疗中的应用前景
Int J Mol Sci. 2024 Feb 26;25(5):2680. doi: 10.3390/ijms25052680.
6
Three-dimensional human bile duct formation from chemically induced human liver progenitor cells.由化学诱导的人肝祖细胞形成三维人胆管
Front Bioeng Biotechnol. 2023 Aug 21;11:1249769. doi: 10.3389/fbioe.2023.1249769. eCollection 2023.
7
On-chip clearing for live imaging of 3D cell cultures.用于3D细胞培养实时成像的片上清除技术。
Biomed Opt Express. 2023 May 31;14(6):3003-3017. doi: 10.1364/BOE.489219. eCollection 2023 Jun 1.
8
Liver organoids: a promising three-dimensional model for insights and innovations in tumor progression and precision medicine of liver cancer.肝类器官:肿瘤进展和肝癌精准医学中洞察和创新的有前途的三维模型。
Front Immunol. 2023 Jun 2;14:1180184. doi: 10.3389/fimmu.2023.1180184. eCollection 2023.
基因调控网络分析和工程指导多谱系人类肝类器官的发育和血管生成。
Cell Syst. 2021 Jan 20;12(1):41-55.e11. doi: 10.1016/j.cels.2020.11.002. Epub 2020 Dec 7.
4
High-Fidelity Drug-Induced Liver Injury Screen Using Human Pluripotent Stem Cell-Derived Organoids.使用人多能干细胞衍生类器官进行高逼真度药物性肝损伤筛选。
Gastroenterology. 2021 Feb;160(3):831-846.e10. doi: 10.1053/j.gastro.2020.10.002. Epub 2020 Oct 8.
5
Generation of multi-cellular human liver organoids from pluripotent stem cells.多能干细胞来源的人类多细胞肝类器官的生成。
Methods Cell Biol. 2020;159:47-68. doi: 10.1016/bs.mcb.2020.03.009. Epub 2020 May 22.
6
Adult and iPS-derived non-parenchymal cells regulate liver organoid development through differential modulation of Wnt and TGF-β.成体和 iPS 细胞来源的非实质细胞通过差异调节 Wnt 和 TGF-β 来调控肝类器官的发育。
Stem Cell Res Ther. 2019 Aug 15;10(1):258. doi: 10.1186/s13287-019-1367-x.
7
Modeling Steatohepatitis in Humans with Pluripotent Stem Cell-Derived Organoids.利用多能干细胞衍生类器官模拟肝脂肪变性。
Cell Metab. 2019 Aug 6;30(2):374-384.e6. doi: 10.1016/j.cmet.2019.05.007. Epub 2019 May 30.
8
Incidence and Etiology of Drug-Induced Liver Injury in Mainland China.中国内地药物性肝损伤的发生率及病因学。
Gastroenterology. 2019 Jun;156(8):2230-2241.e11. doi: 10.1053/j.gastro.2019.02.002. Epub 2019 Feb 8.
9
In situ differentiation and generation of functional liver organoids from human iPSCs in a 3D perfusable chip system.在 3D 可灌注芯片系统中,从人诱导多能干细胞原位分化并生成功能性肝类器官。
Lab Chip. 2018 Dec 7;18(23):3606-3616. doi: 10.1039/c8lc00869h. Epub 2018 Oct 25.
10
Generation of spatial-patterned early-developing cardiac organoids using human pluripotent stem cells.使用人类多能干细胞生成具有空间图案的早期心脏类器官。
Nat Protoc. 2018 Apr;13(4):723-737. doi: 10.1038/nprot.2018.006. Epub 2018 Mar 15.